Sources and physiological significance of plasma dopamine sulfate

D. S. Goldstein, K. J. Swoboda, J. M. Miles, S. W. Coppack, A. Aneman, C. Holmes, I. Lamensdorf, G. Eisenhofer

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Dopamine in the circulation occurs mainly as dopamine sulfate, the sources and physiological significance of which have been obscure. In this study, plasma concentrations of dopamine sulfate were measured after a meal, after fasting for 4 days, and during iv L-DOPA, nitro-prusside, or trimethaphan infusion in volunteers; after dopamine infusion in patients with L-aromatic-amino-acid decarboxylase deficiency; in arterial and portal venous plasma of gastrointestinal surgery patients; and in patients with sympathetic neurocirculatory failure. Meal ingestion increased plasma dopamine sulfate by more than 50-fold; however, prolonged fasting decreased plasma dopamine sulfate only slightly. L-DOPA infusion produced much larger increments in dopamine sulfate than in dopamine; the other drugs were without effect. Patients with L-aromatic amino acid decarboxylase deficiency had decreased dopamine sulfate levels, and patients with sympathetic neurocirculatory failure had normal levels. Decarboxylase-deficient patients undergoing dopamine infusion had a dopamine sulfate/dopamine ratio about 25 times less than that at baseline in volunteers. Surgery patients had large arterial-portal venous increments in plasma concentrations of dopamine sulfate, so that mesenteric dopamine sulfate production accounted for most of urinary dopamine sulfate excretion, a finding consistent with the localization of the dopamine sulfoconjugating enzyme to gastrointestinal tissues. The results indicate that plasma dopamine sulfate derives mainly from sulfoconjugation of dopamine synthesized from L-DOPA in the gastrointestinal tract. Both dietary and endogenous determinants affect plasma dopamine sulfate. The findings suggest an enzymatic gut-blood barrier for detoxifying exogenous dopamine and delimiting autocrine/paracrine effects of endogenous dopamine generated in a 'third catecholamine system'.

Original languageEnglish (US)
Pages (from-to)2523-2531
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume84
Issue number7
StatePublished - 1999
Externally publishedYes

Fingerprint

Sulfates
Dopamine
Plasmas
Aromatic-L-Amino-Acid Decarboxylases
Surgery
Meals
Volunteers
Fasting
Trimethaphan
Carboxy-Lyases

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Goldstein, D. S., Swoboda, K. J., Miles, J. M., Coppack, S. W., Aneman, A., Holmes, C., ... Eisenhofer, G. (1999). Sources and physiological significance of plasma dopamine sulfate. Journal of Clinical Endocrinology and Metabolism, 84(7), 2523-2531.

Sources and physiological significance of plasma dopamine sulfate. / Goldstein, D. S.; Swoboda, K. J.; Miles, J. M.; Coppack, S. W.; Aneman, A.; Holmes, C.; Lamensdorf, I.; Eisenhofer, G.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 84, No. 7, 1999, p. 2523-2531.

Research output: Contribution to journalArticle

Goldstein, DS, Swoboda, KJ, Miles, JM, Coppack, SW, Aneman, A, Holmes, C, Lamensdorf, I & Eisenhofer, G 1999, 'Sources and physiological significance of plasma dopamine sulfate', Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 7, pp. 2523-2531.
Goldstein DS, Swoboda KJ, Miles JM, Coppack SW, Aneman A, Holmes C et al. Sources and physiological significance of plasma dopamine sulfate. Journal of Clinical Endocrinology and Metabolism. 1999;84(7):2523-2531.
Goldstein, D. S. ; Swoboda, K. J. ; Miles, J. M. ; Coppack, S. W. ; Aneman, A. ; Holmes, C. ; Lamensdorf, I. ; Eisenhofer, G. / Sources and physiological significance of plasma dopamine sulfate. In: Journal of Clinical Endocrinology and Metabolism. 1999 ; Vol. 84, No. 7. pp. 2523-2531.
@article{560dabf8b1b44932ad93b8cfc59b7cbd,
title = "Sources and physiological significance of plasma dopamine sulfate",
abstract = "Dopamine in the circulation occurs mainly as dopamine sulfate, the sources and physiological significance of which have been obscure. In this study, plasma concentrations of dopamine sulfate were measured after a meal, after fasting for 4 days, and during iv L-DOPA, nitro-prusside, or trimethaphan infusion in volunteers; after dopamine infusion in patients with L-aromatic-amino-acid decarboxylase deficiency; in arterial and portal venous plasma of gastrointestinal surgery patients; and in patients with sympathetic neurocirculatory failure. Meal ingestion increased plasma dopamine sulfate by more than 50-fold; however, prolonged fasting decreased plasma dopamine sulfate only slightly. L-DOPA infusion produced much larger increments in dopamine sulfate than in dopamine; the other drugs were without effect. Patients with L-aromatic amino acid decarboxylase deficiency had decreased dopamine sulfate levels, and patients with sympathetic neurocirculatory failure had normal levels. Decarboxylase-deficient patients undergoing dopamine infusion had a dopamine sulfate/dopamine ratio about 25 times less than that at baseline in volunteers. Surgery patients had large arterial-portal venous increments in plasma concentrations of dopamine sulfate, so that mesenteric dopamine sulfate production accounted for most of urinary dopamine sulfate excretion, a finding consistent with the localization of the dopamine sulfoconjugating enzyme to gastrointestinal tissues. The results indicate that plasma dopamine sulfate derives mainly from sulfoconjugation of dopamine synthesized from L-DOPA in the gastrointestinal tract. Both dietary and endogenous determinants affect plasma dopamine sulfate. The findings suggest an enzymatic gut-blood barrier for detoxifying exogenous dopamine and delimiting autocrine/paracrine effects of endogenous dopamine generated in a 'third catecholamine system'.",
author = "Goldstein, {D. S.} and Swoboda, {K. J.} and Miles, {J. M.} and Coppack, {S. W.} and A. Aneman and C. Holmes and I. Lamensdorf and G. Eisenhofer",
year = "1999",
language = "English (US)",
volume = "84",
pages = "2523--2531",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Sources and physiological significance of plasma dopamine sulfate

AU - Goldstein, D. S.

AU - Swoboda, K. J.

AU - Miles, J. M.

AU - Coppack, S. W.

AU - Aneman, A.

AU - Holmes, C.

AU - Lamensdorf, I.

AU - Eisenhofer, G.

PY - 1999

Y1 - 1999

N2 - Dopamine in the circulation occurs mainly as dopamine sulfate, the sources and physiological significance of which have been obscure. In this study, plasma concentrations of dopamine sulfate were measured after a meal, after fasting for 4 days, and during iv L-DOPA, nitro-prusside, or trimethaphan infusion in volunteers; after dopamine infusion in patients with L-aromatic-amino-acid decarboxylase deficiency; in arterial and portal venous plasma of gastrointestinal surgery patients; and in patients with sympathetic neurocirculatory failure. Meal ingestion increased plasma dopamine sulfate by more than 50-fold; however, prolonged fasting decreased plasma dopamine sulfate only slightly. L-DOPA infusion produced much larger increments in dopamine sulfate than in dopamine; the other drugs were without effect. Patients with L-aromatic amino acid decarboxylase deficiency had decreased dopamine sulfate levels, and patients with sympathetic neurocirculatory failure had normal levels. Decarboxylase-deficient patients undergoing dopamine infusion had a dopamine sulfate/dopamine ratio about 25 times less than that at baseline in volunteers. Surgery patients had large arterial-portal venous increments in plasma concentrations of dopamine sulfate, so that mesenteric dopamine sulfate production accounted for most of urinary dopamine sulfate excretion, a finding consistent with the localization of the dopamine sulfoconjugating enzyme to gastrointestinal tissues. The results indicate that plasma dopamine sulfate derives mainly from sulfoconjugation of dopamine synthesized from L-DOPA in the gastrointestinal tract. Both dietary and endogenous determinants affect plasma dopamine sulfate. The findings suggest an enzymatic gut-blood barrier for detoxifying exogenous dopamine and delimiting autocrine/paracrine effects of endogenous dopamine generated in a 'third catecholamine system'.

AB - Dopamine in the circulation occurs mainly as dopamine sulfate, the sources and physiological significance of which have been obscure. In this study, plasma concentrations of dopamine sulfate were measured after a meal, after fasting for 4 days, and during iv L-DOPA, nitro-prusside, or trimethaphan infusion in volunteers; after dopamine infusion in patients with L-aromatic-amino-acid decarboxylase deficiency; in arterial and portal venous plasma of gastrointestinal surgery patients; and in patients with sympathetic neurocirculatory failure. Meal ingestion increased plasma dopamine sulfate by more than 50-fold; however, prolonged fasting decreased plasma dopamine sulfate only slightly. L-DOPA infusion produced much larger increments in dopamine sulfate than in dopamine; the other drugs were without effect. Patients with L-aromatic amino acid decarboxylase deficiency had decreased dopamine sulfate levels, and patients with sympathetic neurocirculatory failure had normal levels. Decarboxylase-deficient patients undergoing dopamine infusion had a dopamine sulfate/dopamine ratio about 25 times less than that at baseline in volunteers. Surgery patients had large arterial-portal venous increments in plasma concentrations of dopamine sulfate, so that mesenteric dopamine sulfate production accounted for most of urinary dopamine sulfate excretion, a finding consistent with the localization of the dopamine sulfoconjugating enzyme to gastrointestinal tissues. The results indicate that plasma dopamine sulfate derives mainly from sulfoconjugation of dopamine synthesized from L-DOPA in the gastrointestinal tract. Both dietary and endogenous determinants affect plasma dopamine sulfate. The findings suggest an enzymatic gut-blood barrier for detoxifying exogenous dopamine and delimiting autocrine/paracrine effects of endogenous dopamine generated in a 'third catecholamine system'.

UR - http://www.scopus.com/inward/record.url?scp=0033306462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033306462&partnerID=8YFLogxK

M3 - Article

C2 - 10404831

AN - SCOPUS:0033306462

VL - 84

SP - 2523

EP - 2531

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -